e-learning
resources
Munich 2006
Tuesday 05.09.2006
The challenges of managing asthma in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial
D. E. Shaw, M. A. Berry, M. Thomas, B. Hargadon, S. McKenna, M. J. Shelley, H. J. Pateman, R. H. Green, C. E. Brightling, A. J. Wardlaw, I. D. Pavord (Leicester, Aberdeen, United Kingdom)
Source:
Annual Congress 2006 - The challenges of managing asthma in primary care
Session:
The challenges of managing asthma in primary care
Session type:
Oral Presentation
Number:
3367
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. E. Shaw, M. A. Berry, M. Thomas, B. Hargadon, S. McKenna, M. J. Shelley, H. J. Pateman, R. H. Green, C. E. Brightling, A. J. Wardlaw, I. D. Pavord (Leicester, Aberdeen, United Kingdom). Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial. Eur Respir J 2006; 28: Suppl. 50, 3367
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: randomized parallel-group trial
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Exhaled nitric oxide correlations in patients with controlled and partially controlled asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005
Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Source: Eur Respir J 2014; 44: 1705-1707
Year: 2014
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010
Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study
Source: Eur Respir J 2012; 39: 567-572
Year: 2012
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
The relationship between exhaled nitric oxide and body mass index in controlled an uncontrolled Tunisian asthmatics
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Physical training does not increase allergic inflammation in asthmatic children
Source: Eur Respir J 2008; 32: 1570-1575
Year: 2008
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
The effect of bronchodilation and spirometry on exhaled nitric oxide
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Exhaled nitric oxide may predict future benefit in patients with poorly controlled asthma
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept